A Neurocognitive Model of Anorexia Nervosa
2 other identifiers
observational
152
0 countries
N/A
Brief Summary
The purpose of this study is to investigate thought processes and neural mechanisms that may contribute to the development of habitual behaviors. The investigators hypothesize that patients with AN will perform differently than people without eating disorders on a series of neuropsychological tasks and will show different neural activation patterns in functional neuroimaging scans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2006
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedFirst Submitted
Initial submission to the registry
May 12, 2006
CompletedFirst Posted
Study publicly available on registry
May 15, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedAugust 15, 2014
July 1, 2013
8 years
May 12, 2006
August 14, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Neuropsychological functioning
pre- and post-treatment
Study Arms (2)
Anorexia nervosa
Individuals with anorexia nervosa receiving inpatient treatment
Healthy controls
Eligibility Criteria
Patients with Anorexia Nervosa or Healthy Volunteers
You may qualify if:
- DSM-IV-TR™ diagnosis of anorexia nervosa (restricting or binge-purge subtype), current or prior;
- Age 16-45;
- Inpatient on GCRU
- Medically stable.
You may not qualify if:
- Any other current major Axis I disorder (including current bulimia nervosa), except major depression;
- History of concussion, seizure disorder, or other neurological illness;
- History of learning disability;
- Acute Suicidality
- Healthy comparison group:
- No current or past psychiatric illness;
- Age 16-45
- No history of binge eating or vomiting;
- Normal weight (80%-120% ideal body weight)
- Significant medical or neurologic illness(concussion, seizure disorder, learning disability, other neurological illness)
- Current psychotropic medication or medications known to impact cognition
- Significant Claustrophobia
- Pregnancy
- Indwelling metallic object, non-removable metal jewelry, medicinal patch or recent metallic ink tattoo
- For patients, current psychotropic medications (antidepressants for 2 week (prozac and antipsychotics for 4 weeks)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- New York State Psychiatric Institutelead
- Klarman Family Foundationcollaborator
- National Institute of Mental Health (NIMH)collaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna Steinglass, MD
New York State Psychiatric Institute
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2006
First Posted
May 15, 2006
Study Start
May 1, 2006
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
August 15, 2014
Record last verified: 2013-07